May 17, 2023 | DKD
2) Christos Argyropoulos MD, PhD @ChristosArgyrop is Division Chief, Nephrology @UNMHSC. #CKD is chronic #kidneydisease, #ESKD is end-stage kidney disease.#FOAMed #nephtwitter #cardiotwitter @MedTweetorials @NephUCommunity @ISNkidneycare @KidneyDiseaseFm...
May 2, 2023 | DKD
1b) .@edgarvlermamd will be reviewing the mechanism of action #MOA of #mineralocorticoid receptor antagonists #MRAs in potential #renoprotection for pts with #CKD. He will also address the differences between #steroidal and #nonsteroidal MRA therapies...
Apr 10, 2023 | DKD
2) This #tweetorial is supported by an unrestricted educational grant from Bayer and is intended for healthcare providers.— @CKD_ce (@ckd_ce) April 11, 2023 4) How do we know which pts with #T2D are at risk for #CKD? @AmDiabetesAssn & @goKDIGO recently...
Feb 6, 2023 | DKD
2) This program is supported by an educational grant from Sanofi and is intended for healthcare professionals. Statement of accreditation and disclosures are listed at https://t.co/PHlIpplEO4. See prior programs and earn 🆓credit at https://t.co/L4qK6GpsLH.—...
Jan 9, 2023 | DKD
2) This #accredited #tweetorial on #kidneydisease #CKD is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance. It is not intended for US- or UK-based based HCPs. Accreditation statement & faculty disclosures at...
Jan 3, 2023 | DKD
2) This #accredited #tweetorial series on #kidneydisease #CKD is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance. It is not intended for US- or UK-based HCPs. Accreditation statement & faculty disclosures at...